Previous close | 71.05 |
Open | 71.05 |
Bid | 99.20 |
Ask | 107.90 |
Strike | 865.00 |
Expiry date | 2024-06-21 |
Day's range | 71.05 - 71.05 |
Contract range | N/A |
Volume | |
Open interest | 12 |
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
Regeneron Pharmaceuticals ( NASDAQ:REGN ) First Quarter 2024 Results Key Financial Results Revenue: US$3.15b (flat on...
Discover how Regeneron sustains robust growth with significant advancements in clinical programs and strategic market maneuvers.